IGC Pharma, Inc. (IGC): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$4.91M
Year ended 2025-03-31
-$5.63M
Trailing 12 months to 2025-09-30
$238.8K2011-03-31: -$2.92M2012-03-31: -$5.03M2013-03-31: $238.8K2014-03-31: -$1.75M2015-03-31: -$2.66M2016-03-31: -$279.9K2017-03-31: -$1.54M2018-03-31: -$2.07M2019-03-31: -$3.35M2020-03-31: -$13.07M2021-03-31: -$12.27M2022-03-31: -$7.70M2023-03-31: -$7.36M2024-03-31: -$5.34M2025-03-31: -$4.91M-$4.91M
2011-03-31 Free Cash Flow (USD) 2025-03-31
Period endedFree Cash FlowChange YoYSource filing
2025-03-31-$4.91Mn/m2025-06-27, From 2024-04-01
2024-03-31-$5.34Mn/m2025-06-27, From 2023-04-01
2023-03-31-$7.36Mn/m2024-06-24, From 2022-04-01
2022-03-31-$7.70Mn/c2023-07-07, From 2021-04-01
2021-03-31-$12.27Mn/m2022-06-23, From 2020-04-01
2020-03-31-$13.07Mn/m2021-06-14, From 2019-04-01
2019-03-31-$3.35Mn/m2020-07-13, From 2018-04-01
2018-03-31-$2.07Mn/m2019-06-14, From 2017-04-01
2017-03-31-$1.54Mn/m2018-06-21, From 2016-04-01
2016-03-31-$279.9Kn/m2017-07-14, From 2015-04-01
2015-03-31-$2.66Mn/m2016-07-14, From 2014-04-01
2014-03-31-$1.75Mn/m2015-07-14, From 2013-04-01
2013-03-31$238.8Kn/m2014-07-15, From 2012-04-01
2012-03-31-$5.03Mn/m2014-07-15, From 2011-04-01
2011-03-31-$2.92Mn/a2012-07-16, From 2010-04-01